))
Journal Club: March April Issue of OPRS
Manage episode 414581533 series 3559327
Content provided by Tim Cicciarelli and The InBound Podcasting Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Tim Cicciarelli and The InBound Podcasting Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
About the Guest:
Dr. Don Kikkawa is a respected figure in the field of ophthalmology, serving as a professor at the University of California, San Diego Shiley Eye Institute. As a former president of ASOPRS, he holds the prestigious Hollander Chair and boasts considerable expertise in the realm of thyroid eye disease treatments, contributing extensively to scholarly research.
Dr. Cesar A. Briceno is an accomplished advisory dean and associate professor of ophthalmology at the University of Pennsylvania Scheie Eye Institute. His professional journey has been marked by a keen focus on cutting-edge clinical trials and advancements in the autoimmune aspects of ocular disease.
Dr. Kira L. Segal is an oculofacial surgeon practicing at the EltraSelf Advanced Facial Aesthetics in Florham Park, New Jersey. Additionally, she extends her expertise as a voluntary faculty member at the Weill Cornell University School of Medicine. Dr. Segal’s contributions to the field, particularly in preoperative evaluation and surgical techniques, have earned her a reputable standing.
Episode Summary:
In this enriching episode of the Oculofacial Podcast Journal Club, host Lilangi Ediriwickrema, MD, as she moderates a discussion with experts Don Kikkawa, MD, Cesar A. Briceno, MD, and Kira L. Segal, MD, on three recent articles published in the field of oculofacial surgery. The panel reviews a study on proptosis regression after teprotumumab treatment, the current uses of amniotic membrane transplantation, and the association between obstructive sleep apnea and ptosis repair failure. They delve into the findings, limitations, and potential implications of each study, providing valuable insights for oculofacial surgeons and patients alike. Don't miss this engaging and informative episode of the Oculofacial Podcast Journal Club.
Key Takeaways:
- Teprotumumab treatment for thyroid eye disease shows varying rates of proptosis regression in patients, signaling the potential need for personalized retreatment strategies.
- Amniotic membrane transplantation offers diverse applications in oculoplastic surgery and holds promise in enhancing patient outcomes for various reconstructive procedures.
- The presence of obstructive sleep apnea in patients correlates with higher failure rates of ptosis repair, warranting a more cautious preoperative evaluation and emphasizing the complexity of ptosis surgery in such cases.
- Staging surgical interventions, especially in cases of tarsal instability and floppy eyelid syndrome, can improve outcomes and minimize potential complications.
- Medical compliance in managing sleep apnea plays a role in patient outcomes, although further study is needed to understand the full impact on oculofacial surgical procedures.
If you're an ASOPRS Member, Surgeon or Trainee and are interesting in hosting a podcast episode, please submit your idea by visiting: asoprs.memberclicks.net/podcast
35 episodes
Share
